Publications by authors named "Bernard-Arnoux F"
Background: There is strong concern about the costs associated with adding tumor-treating fields (TTF) therapy to standard first-line treatment for glioblastoma (GBM). Hence, we aimed to determine the cost-effectiveness of TTF therapy for the treatment of newly diagnosed patients with GBM.
Methods: We developed a 3-health-state Markov model.